TMPRSS11C inhibitors are a class of chemical compounds designed to target and inhibit the activity of the TMPRSS11C protein, a transmembrane serine protease involved in regulating various biological processes, particularly those associated with proteolytic cleavage. These inhibitors primarily function by binding to the active site of the TMPRSS11C protein, where they block the interaction between the enzyme and its natural substrates. This blockage prevents the TMPRSS11C protein from catalyzing proteolysis, effectively halting its enzymatic function. In some cases, TMPRSS11C inhibitors may also act through allosteric inhibition, binding to regions of the protein that are distinct from the active site. This allosteric binding can induce conformational changes in the protein, reducing its catalytic efficiency or completely inhibiting its function. The interaction between these inhibitors and the TMPRSS11C protein is maintained by non-covalent forces such as hydrogen bonds, van der Waals interactions, hydrophobic contacts, and ionic bonds, which ensure that the inhibitors are stably bound to the protein and exert their inhibitory effects effectively.
Structurally, TMPRSS11C inhibitors are diverse, ranging from small organic molecules to larger, more complex chemical frameworks. These inhibitors often include functional groups such as hydroxyl, carboxyl, or amine groups, which allow them to form specific hydrogen bonds or ionic interactions with the amino acid residues in the TMPRSS11C protein's active or allosteric sites. Additionally, many TMPRSS11C inhibitors feature aromatic rings and heterocyclic structures that facilitate hydrophobic interactions with non-polar regions of the protein, further enhancing binding stability. The physicochemical properties of TMPRSS11C inhibitors-such as molecular weight, solubility, lipophilicity, and polarity-are carefully optimized to ensure that they can effectively bind to the TMPRSS11C protein and remain stable in different biological environments. Hydrophobic regions within the inhibitors allow them to interact with non-polar regions of the protein, while polar groups enable solubility and promote specific interactions with polar residues. This balance between hydrophilic and hydrophobic properties ensures that TMPRSS11C inhibitors achieve strong and selective binding, modulating the activity of the protein across a variety of conditions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $29.00 $38.00 | 18 | |
Indomethacin might inhibit transmembrane protease, serine 11c expression by interfering with transcription factors involved in its gene regulation, thus downregulating its synthesis. | ||||||
Triclosan | 3380-34-5 | sc-220326 sc-220326A | 10 g 100 g | $141.00 $408.00 | ||
Triclosan could potentially inhibit transmembrane protease, serine 11c expression by disrupting cellular processes essential for its translation and post-translational modification. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane may inhibit transmembrane protease, serine 11c expression by modulating epigenetic mechanisms that control accessibility of its gene for transcription. | ||||||
Clotrimazole | 23593-75-1 | sc-3583 sc-3583A | 100 mg 1 g | $42.00 $57.00 | 6 | |
Clotrimazole might inhibit transmembrane protease, serine 11c expression by interfering with intracellular signaling pathways crucial for its transcriptional activation. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Berberine could potentially inhibit transmembrane protease, serine 11c expression by modulating the activity of transcription factors essential for its gene regulation. | ||||||
Oleanolic Acid | 508-02-1 | sc-205775 sc-205775A | 100 mg 500 mg | $86.00 $302.00 | 8 | |
Oleanolic acid may inhibit transmembrane protease, serine 11c expression by interfering with the synthesis of components necessary for its proper folding and membrane insertion. | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $58.00 $95.00 $245.00 $727.00 | 8 | |
Ellagic acid might inhibit transmembrane protease, serine 11c expression by modulating the activity of enzymes involved in post-translational modification processes. | ||||||
Silymarin group, mixture of isomers | 65666-07-1 | sc-301806 | 50 g | $325.00 | ||
Silymarin could potentially inhibit transmembrane protease, serine 11c expression by interfering with signaling pathways crucial for its transcriptional regulation. | ||||||
Ursolic Acid | 77-52-1 | sc-200383 sc-200383A | 50 mg 250 mg | $56.00 $180.00 | 8 | |
Ursolic acid may inhibit transmembrane protease, serine 11c expression by modulating the activity of transcription factors involved in its gene expression and protein synthesis. | ||||||
Allicin | 539-86-6 | sc-202449 sc-202449A | 1 mg 5 mg | $489.00 $1557.00 | 7 | |
Allicin might inhibit transmembrane protease, serine 11c expression by disrupting cellular processes essential for its post-translational modification and membrane insertion. | ||||||